Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2020 1
2021 6
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Is immunotherapy in the future of therapeutic management of sarcomas?
Clemente O, Ottaiano A, Di Lorenzo G, Bracigliano A, Lamia S, Cannella L, Pizzolorusso A, Di Marzo M, Santorsola M, De Chiara A, Fazioli F, Tafuto S. Clemente O, et al. J Transl Med. 2021 Apr 26;19(1):173. doi: 10.1186/s12967-021-02829-y. J Transl Med. 2021. PMID: 33902630 Free PMC article. Review.
Malignant Sinonasal Tumors: Update on Histological and Clinical Management.
Bracigliano A, Tatangelo F, Perri F, Di Lorenzo G, Tafuto R, Ottaiano A, Clemente O, Barretta ML, Losito NS, Santorsola M, Tafuto S. Bracigliano A, et al. Among authors: clemente o. Curr Oncol. 2021 Jul 1;28(4):2420-2438. doi: 10.3390/curroncol28040222. Curr Oncol. 2021. PMID: 34287240 Free PMC article. Review.
The Complex Management of the Breast Angiosarcoma: A Retrospective Study.
Cannella L, Perri F, Clemente O, von Arx C, Pizzolorusso A, Di Bonito M, Bracigliano A, Di Marzo M, Della Vittoria Scarpati G, De Chiara A, Tafuto S. Cannella L, et al. Among authors: clemente o. Oncology. 2023;101(4):234-239. doi: 10.1159/000525146. Epub 2022 Dec 20. Oncology. 2023. PMID: 36538913
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives.
Bracigliano A, Marretta AL, Guerrera LP, Simioli R, Clemente O, Granata V, Minopoli A, Della Vittoria Scarpati G, Picozzi F, Cannella L, Pizzolorusso A, Di Gennaro F, Tafuto R, Sarno MR, Cavalcanti E, Ribera D, Tafuto S. Bracigliano A, et al. Among authors: clemente o. Pharmaceuticals (Basel). 2024 Mar 8;17(3):354. doi: 10.3390/ph17030354. Pharmaceuticals (Basel). 2024. PMID: 38543140 Free PMC article. Review.
The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine.
Cannella L, Della Monica R, Marretta AL, Iervolino D, Vincenzi B, De Chiara AR, Clemente O, Buonaiuto M, Barretta ML, Di Mauro A, Di Marzo M, Guida M, Badalamenti G, Chiariotti L, Tafuto S. Cannella L, et al. Among authors: clemente o. Cells. 2023 Jun 15;12(12):1635. doi: 10.3390/cells12121635. Cells. 2023. PMID: 37371106 Free PMC article.
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability.
Lauricella E, Cives M, Bracigliano A, Clemente O, Felici V, Lippolis R, Amoruso B, Pelle' E, Mandriani B, Esposto C, Forte C, Perri F, Porta C, Tafuto S. Lauricella E, et al. Among authors: clemente o. J Neuroendocrinol. 2021 Sep 20;33(10):e13041. doi: 10.1111/jne.13041. Online ahead of print. J Neuroendocrinol. 2021. PMID: 34596289 Free PMC article.
Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Di Mauro A, Scognamiglio G, Aquino G, Cerrone M, Liguori G, Clemente O, Di Bonito M, Cantile M, Botti G, Tafuto S, Tatangelo F. Di Mauro A, et al. Among authors: clemente o. Int J Mol Sci. 2021 Jun 30;22(13):7049. doi: 10.3390/ijms22137049. Int J Mol Sci. 2021. PMID: 34208964 Free PMC article.
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Ottaiano A, Scala S, Santorsola M, Trotta AM, D'Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: clemente o. Ther Adv Med Oncol. 2021 Mar 24;13:1758835921989223. doi: 10.1177/1758835921989223. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854566 Free PMC article.
13 results